Can stem cells from urine help kidneys? small trial tests safety

NCT ID NCT06071143

Completed Disease control Sponsor: EHL Bio Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-phase study tested whether stem cells taken from a patient's own urine (called KDSTEM Inj.) are safe for people with chronic kidney disease. Six participants received low or high doses of the cells through an IV. The main goal was to check for side effects, while also looking at kidney function changes. Because this is a very small, early trial, it cannot say if the treatment works, but it may guide future research.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: urine-derived stem cells (KDSTEM Inj.)
What this could lead to: If this works, it could point toward a new way to slow or manage chronic kidney disease using a patient's own stem cells.
What could go wrong: This is a very early, tiny Phase 1 safety study with only 6 people. It cannot prove effectiveness, and stem cell treatments carry unknown risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC KIDNEY DISEASES

Contacts and locations

Locations

Chungnam National University Hospital

Daejeon, Chungcheongnam-do, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.